Logo.jpg
Biofrontera reports preliminary approximate revenues for the month of September 2021
October 01, 2021 07:44 ET | Biofrontera AG
Leverkusen, Germany, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
Logo_Biofrontera_AG.png
Biofrontera shows robust growth during first six months of 2019
August 27, 2019 02:15 ET | Biofrontera AG
Leverkusen, Germany, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
Logo_Biofrontera_AG.png
Biofrontera provides update on Cutanea integration
August 05, 2019 09:00 ET | Biofrontera AG
Leverkusen, Germany, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company,...